Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,955
Funds Holding Change
+7
Funds Holding Growth
+0.1%
Value
$1.44T
Holding in Top 10
1,154
Top 10 Change
-112
Top 10 Growth
-9%
Value Growth
-2%
New
167
Increased
2,093
Reduced
2,369
Closed
118
Capital Inflow
$38.5B
Capital Outflow
$43.7B
Net Capital Flow
-$5.24B
Capital Flow Change
-$23.1B
Calls
$20.3B
Puts
$18.1B
Net Calls
+$2.16B
Put/Call Ratio
0.89